Sentinel lymph node biopsy after neoadjuvant chemotherapy predicts pathological axillary lymph node status in breast cancer patients with clinically positive axillary lymph nodes at presentation

International Journal of Clinical Oncology

Volumn 18, Issue 3, 2013, Pages 547-553

  Takei, Hiroyuki ^a   Yoshida, Takashi ^a   Kurosumi, Masafumi ^a   Inoue, Kenichi ^a   Matsumoto, Hiroshi ^a   Hayashi, Yuji ^a   Higuchi, Toru ^a   Uchida, Sayaka ^a   Ninomiya, Jun ^a   Kubo, Kazuyuki ^a   Oba, Hanako ^a   Nagai, Shigenori ^a   Tabei, Toshio ^a  

^a SAITAMA CANCER CENTER   (Japan)

Author keywords

Axillary lymph node dissection; Breast cancer; Neoadjuvant chemotherapy; Sentinel lymph node

Indexed keywords

ANTHRACYCLINE; CYCLOPHOSPHAMIDE; EPIRUBICIN; ESTROGEN RECEPTOR; FLUOROURACIL; TAXANE DERIVATIVE; TRASTUZUMAB;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER LOCALIZATION; CANCER PROGNOSIS; CANCER SIZE; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FALSE NEGATIVE RESULT; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRAOPERATIVE PERIOD; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; PRIORITY JOURNAL; SENTINEL LYMPH NODE BIOPSY; TUMOR INVASION;

ADULT; AGED; AXILLA; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY;

EID: 84879420824     PISSN: 13419625     EISSN: 14377772     Source Type: Journal    
DOI: 10.1007/s10147-012-0418-4     Document Type: Article

References (39)

1. Kim T, Giuliano AE, Lyman GH (2006) Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis. Cancer 106:4-16
2. Lyman GH, Giuliano AE, Somerfield MR et al (2005) American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 23:7703-7720
3. Veronesi U, Paganelli G, Viale G et al (2006) Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomized controlled study. Lancet Oncol 7:983-989
4. Krag DN, Anderson SJ, Julian TB, National Surgical Adjuvant Breast and Bowel Project et al (2007) Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol 8:881-888
5. Krag DN, Anderson SJ, Julian TB et al (2010) Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol 11:927-933
6. Takei H, Kurosumi M, Yoshida T et al (2007) Current trends of sentinel lymph node biopsy for breast cancer - a surgeon's perspective. Breast Cancer 14:362-370
7. Nieweg OE, Estourgie SH (2004) What is a sentinel node and what is a false-negative sentinel node? Ann Surg Oncol 11:169S-173S
8. Van Zee KJ, Manasseh DM, Bevilacqua JL et al (2003) A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol 10:1140-1151
9. Gur AS, Unal B, Johnson R et al (2009) Predictive probability of four different breast cancer nomograms for nonsentinel axillary lymph node metastasis in positive sentinel node biopsy. J Am Coll Surg 208:229-235
10. Rivers AK, Griffith KA, Hunt KK et al (2006) Clinicopathologic features associated with having four or more metastatic axillary nodes in breast cancer patients with a positive sentinel lymph node. Ann Surg Oncol 13:36-44
11. Alkhatib W, Connor C, Fang F (2007) Solitary positive sentinel lymph node accompanied by negative sentinel lymph node(s) is predictive of a negative completion axillary lymph node dissection. Am J Surg 194:856-859
12. Katz A, Smith BL, Golshan M et al (2008) Nomogram for the prediction of having four or more involved nodes for sentinel lymph node-positive breast cancer. J Clin Oncol 26:2093-2098
13. Takei H, Kurosumi M, Yoshida T et al (2009) Positive sentinel lymph node biopsy predicts the number of metastatic axillary nodes of breast cancer. Breast 18:244-247
14. Park J, Fey JV, Naik AM et al (2007) A declining rate of completion axillary dissection in sentinel lymph node-positive breast cancer patients is associated with the use of a multivariate nomogram. Ann Surg 245:462-468
15. Giuliano AE, Hunt KK, Ballman KV et al (2011) Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 305:569-575
16. Fisher B, Brown A, Mamounas E et al (1997) Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. J Clin Oncol 15:2483-2493
17. van Nes JG, Putter H, Julien JP et al (2009) Preoperative chemotherapy is safe in early breast cancer, even after 10 years of follow-up; clinical and translational results from the EORTC trial 10902. Breast Cancer Res Treat 115:101-113
18. Mamounas EP, Brown A, Anderson S et al (2005) Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol 23:2694-2702
19. Classe JM, Bordes V, Campion L et al (2009) Sentinel lymph node biopsy after neoadjuvant chemotherapy for advanced breast cancer: results of Ganglion Sentinelle et Chimiotherapie Neoadjuvante, a French prospective multicentric study. J Clin Oncol 27:726-732
20. Buchholz TA, Lehman CD, Harris JR et al (2008) Statement of the science concerning locoregional treatments after preoperative chemotherapy for breast cancer: a National Cancer Institute conference. J Clin Oncol 26:791-797
21. Takei H, Suemasu K, Kurosumi M et al (2002) Sentinel lymph node biopsy without axillary dissection after an intraoperative negative histological investigation in 358 invasive breast cancer cases. Breast Cancer 9:344-348
22. Therasse P, Arbuck SG, Eisenhauer EA et al (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92:205-216
23. 99mTc-human serum albumin as a radioactive tracer for sentinel lymph node biopsy in breast cancer. Surg Today 36:219-224
24. Takei H, Suemasu K, Kurosumi M et al (2006) Added value of the presence of blue nodes or hot nodes in sentinel lymph node biopsy of breast cancer. Breast Cancer 13:179-185
25. Takei H, Suemasu K, Kurosumi M et al (2007) Recurrence after sentinel lymph node biopsy with or without axillary lymph node dissection in patients with breast cancer. Breast Cancer 14:16-24
26. Kurosumi M, Akiyama F, Iwase T et al (2001) Histopathological criteria for assessment of therapeutic response in breast cancer. Breast Cancer 8:1-2
27. Kurosumi M, Akashi-Tanaka S, Akiyama F et al (2008) Histopathological criteria for assessment of therapeutic response in breast cancer (2007 version). Breast Cancer 15:5-7
28. International Union Against Cancer UICC (2002) In: Sobin LH, Witterkind CH (eds) TNM classification of malignant tumours, 6th edn. Wiley-Liss, New York
29. Xing Y, Foy M, Cox DD et al (2006) Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer. Br J Surg 93:539-546
30. van Deurzen CH, Vriens BE, Tjan-Heijnen VC et al (2009) Accuracy of sentinel node biopsy after neoadjuvant chemotherapy in breast cancer patients: a systematic review. Eur J Cancer 45:3124-3130
31. Kelly AM, Dwamena B, Cronin P, Carlos RC (2009) Breast cancer sentinel node identification and classification after neoadjuvant chemotherapy-systematic review and meta analysis. Acad Radiol 16:551-563
32. Jeruss JS, Newman LA, Ayers GD et al (2008) Factors predicting additional disease in the axilla in patients with positive sentinel lymph nodes after neoadjuvant chemotherapy. Cancer 112:2646-2654
33. Gimbergues P, Abrial C, Durando X et al (2009) Clinicopathological factors and nomograms predicting nonsentinel lymph node metastases after neoadjuvant chemotherapy in breast cancer patients. Ann Surg Oncol 16:1946-1951
34. Ozmen V, Unal ES, Muslumanoglu ME et al (2010) Axillary sentinel node biopsy after neoadjuvant chemotherapy. Eur J Surg Oncol 36:23-29
35. Pecha V, Kolarik D, Kozevnikova R et al (2011) Sentinel lymph node biopsy in breast cancer patients treated with neoadjuvant chemotherapy. Cancer 117:4606-4616
36. Tausch C, Konstantiniuk P, Kugler F et al (2008) Sentinel lymph node biopsy after preoperative chemotherapy for breast cancer: findings from the Austrian Sentinel Node Study Group. Ann Surg Oncol 15:3378-3383
37. Shimazu K, Tamaki Y, Taguchi T et al (2008) Intraoperative frozen section analysis of sentinel lymph node in breast cancer patients treated with neoadjuvant chemotherapy. Ann Surg Oncol 15:1717-1722
38. Rubio IT, Aznar F, Lirola J et al (2010) Intraoperative assessment of sentinel lymph nodes after neoadjuvant chemotherapy in patients with breast cancer. Ann Surg Oncol 17:235-239
39. Straver ME, Rutgers EJ, Russell NS et al (2009) Towards rational axillary treatment in relation to neoadjuvant therapy in breast cancer. Eur J Cancer 45:2284-2292